This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Abbvie Stemcentrx LLC. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Innovations of Alexander Schammel in Cancer Treatment
Introduction
Alexander Schammel is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of cancer treatment through his innovative work in antibody drug conjugates. His research focuses on developing novel therapies that can improve patient outcomes.
Latest Patents
Schammel holds a patent for "Anti-SEZ6 antibody drug conjugates and methods of use." This patent provides novel anti-SEZ6 antibodies and antibody drug conjugates, along with methods for using these innovations to treat cancer. His work represents a promising advancement in targeted cancer therapies.
Career Highlights
Schammel is currently employed at AbbVie Stemcentrx LLC, where he continues to push the boundaries of cancer research. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking developments in oncology.
Collaborations
Some of his notable coworkers include David Y. Liu and Julia Gavrilyuk. Their combined expertise enhances the research environment and fosters innovative solutions in cancer treatment.
Conclusion
Alexander Schammel's work exemplifies the impact of innovation in the medical field, particularly in cancer therapy. His contributions through patents and collaboration with esteemed colleagues highlight the importance of research in developing effective treatments.